Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressant Response in Older Adults With Comorbid PTSD and MDD
NCT04697693Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, duloxetine in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Mar 2021; status: terminated.
02
Drugs
escitalopramduloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04697693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697693.